Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 30 Biotech Angel Investors in Switzerland in May 2025

Last updated: May 2025 A list of 30 angel investors that invest in Biotech startups based in Switzerland. We rank investors based on the number of investments they made in Biotech companies from Switzerland. We update this investor list every month.

Top 30 Biotech Angel Investors in Switzerland in May 2025

Investor	Biotech Switzerland investments
Penny Schiffer	4
Nicolas Mermod	1
Igor Fish	1
Ulf Claesson	1
Thorsten Schroeder	1
Mathias Maurer	1
Peter Herger	1
Philip Wels	1
Piero Novelli	1
Urs Berger	1
Ian Metcalfe	1
Marcello Campanelli	1
Ulf Claesson	1
Delia Schrafl	1
Tej Tadi	1
Arda Kara	1
Reinhard Ambros	1
Lukas Speiser	1
Tobias Reichmuth	1
Emily Leproust	1
Patrick Delarive	1
Chris Gibson	1
Feike Sijbesma	1
Lucian Wagner	1
Thomas Glocer	1
Zürcher Kantonalbankand	1
John Zimmer	1
Walter Fischl	1
Beat Schillig	1
Alexsis de Raadt-St. James	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Penny Schiffer - CEO & Co-founder @ Raized.ai

Investment focus

Health Care, Medical, Finance
Funding Round, Seed, Series A
Switzerland, Germany, United Kingdom

Portfolio highlights

Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.

Nicolas Mermod

Investment focus

Medical, Health Care, Life Science
Series A
Switzerland

Portfolio highlights

NewBiologix — NewBiologix operates as a technology innovation company, develops a proprietary and breakthroughDNA integration platform for the advanced engineering of human and mammaliancell lines.

Igor Fish

Investment focus

Medical, Health Care, Life Science
Series A
Switzerland

Portfolio highlights

NewBiologix — NewBiologix operates as a technology innovation company, develops a proprietary and breakthroughDNA integration platform for the advanced engineering of human and mammaliancell lines.

Ulf Claesson

Investment focus

Biotechnology, Food and Beverage
Seed
Switzerland

Portfolio highlights

MIRAI FOODS — Love meat? Mirai aims to produce the meat of the future by cultivating animal cells in a controlled environment

Thorsten Schroeder

Investment focus

Electronics, Children, Life Science
Seed, Series B, Funding Round
United States, Brazil, Switzerland

Portfolio highlights

Storypod — The screen-free, educational audio toy that engages children independently & makes learning fun. Storypod delights toddlers, preschoolers, 1st, & 2nd graders with music, stories, songs, audiobooks, & podcasts. The Storypod audio player features recording from any phone, bedtime nightlight, sound machine, & white noise.
TROCAFONE — Trocafone is the first end-to-end e-commerce marketplace of LATAM that enable people to buy and sell used electronics hassle free, focused on smartphones in Brazil. At Trocafone they improve the selling and buying experience by acquiring the devices from sellers, refurbishing and re-selling them as pre-owned certified. Buyers enjoy the greatdeals of a peer-to-peer marketplace combined with the service, convenience, and safety of a retail store. Sellers enjoy a streamlined experience since It takes seconds to sell an item, and shipping is effortless with Trocafone's pre-addressed, pre-stamped mailers.
4D Lifetec — 4D Lifetec is a biotechnology company promoting and developing screening and test systems for molecular diagnostics. It also offers a unique solution for DNA defect and repair based screening programs and is, therefore, the diagnostic method of the first choice. The company profits from different networks in science and healthcare.4D Lifetecprovides kits, reagents, download center, 4D life tanks, and service packages. They also offer cost savings for healthcare provider by its outstanding precision and a high degree of standardization both leading to a reduction of false positive results.4D Lifetec was founded by Dr. Arne Faisst and Nick Mijnssen in 2014 and is headquartered in Cham, Zug.

Mathias Maurer

Investment focus

Wellness, Neuroscience, Information Technology
Pre-Seed
Switzerland

Portfolio highlights

MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.

Peter Herger is a private investor.

Investment focus

Wellness, Neuroscience, Information Technology
Pre-Seed
Switzerland

Portfolio highlights

MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.

Philip Wels is an individual investor.

Investment focus

Sports, Software, Information Technology
Pre-Seed
Switzerland

Portfolio highlights

BreezeLabs — Our Vision
MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.

Piero Novelli is the Chairman-Supervisory Board at Euronext NV.

Investment focus

Wellness, Neuroscience, Information Technology
Pre-Seed
Switzerland

Portfolio highlights

MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.

Urs Berger is the current President of Swiss Entrepreneurs Foundation. He previously worked at JAROWA AG as a Chairman of the Board. Urs Berger attended Northwestern University - Kellogg School of Management.

Investment focus

Wellness, Neuroscience, Information Technology
Pre-Seed
Switzerland

Portfolio highlights

MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.

Ian Metcalfe is an individual investor.

Investment focus

Biotechnology
Pre-Seed
Switzerland

Portfolio highlights

CellX Biosolutions — CellX Biosolutions is the Sustainable treatment of chemical waste.

Marcello Campanelli is a general manager at Parker Lord.

Investment focus

Biotechnology
Pre-Seed
Switzerland

Portfolio highlights

CellX Biosolutions — CellX Biosolutions is the Sustainable treatment of chemical waste.

Ulf Claesson is a Partner (since 2009) at BLR & Partners AG, a private equity firm located in Zurich, Switzerland. From 2006 to 2009, Ulf built up and ran one of HP’s product divisions as a General Manager and Vice President after having one of his companies acquired by Hewlett-Packard Corporation. From 2002 to 2006, Ulf was Co-founderand Chairman of the Board of Directors at Silverwire Group (now a Hewlett-Packard Company). Ulf has served as a Member of the Board of Directors at AVAST Software since October 2012. Prior to co-founding Silverwire Group, in 1997 Ulf founded Whitecap GmbH and Whitecap LLP, where he also serves as Managing Director to this day. From 1977 to 1997, Ulf served in various European and global management and executive positions at IBM Corporation, where he, among other new business segments, built up IBM’s global Distribution business and its OEM business in Continental Europe. Ulf also serves as a Member of the Board of the Swiss Federal Commission for Innovation and Technology and is a Lecturer, teaching Entrepreneurship at the Swiss Federal Institute of Technology in Zurich. Ulf holds a M.Sc. degree from Chalmers University of Technology in Gothenburg, Sweden.

Investment focus

Biotechnology, Food and Beverage
Seed
Switzerland

Portfolio highlights

MIRAI FOODS — Love meat? Mirai aims to produce the meat of the future by cultivating animal cells in a controlled environment

Delia Schrafl serves as an Advisor to the Investment Committee of Evoleen Invest AG.

Investment focus

Wellness, Neuroscience, Information Technology
Pre-Seed
Switzerland

Portfolio highlights

MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.

Tej Tadi is an Electronics Engineer and has pursued an advanced master in Virtual Reality & Computer Graphics at The Swiss Federal Institute of Technology (EPFL), Switzerland. During his PhD (EPFL), he set up an immersive virtual reality system in combination with state-of-the-art brain imaging technologies enabling trans-disciplinary work incognitive psychology, neuroimaging, and virtual reality. His research has led to important and highly visible scientific publications (Science) and awards (Pfizer Award for Neuroscience in 2009). Through his research, he has built a strong multi-disciplinary base spanning computer science, systems biology, neuroimaging, and computational and cognitive neuroscience. He founded MindMaze in 2011 to design and develop novel applications in Neuro-Rehabilitation, Game training & Interfaces. The technology platform from MindMaze will help in the neurology, psychiatry and sports rehabilitation.

Investment focus

Robotics, Neuroscience
Seed
Switzerland

Portfolio highlights

Metaphysiks — Metaphysiks is a groundbreaking immersive technology company combining world leading neuroscience and robotics to create multisensory experiences.

Arda Kara

Investment focus

Health Care, Medical, Software
Series A, Seed, Series B
United States, Germany, Switzerland

Portfolio highlights

Human API — Health data platform that connects to all data sources, enabling companies to build new technologies & deliver better experiences to customers.
Levels — Levels helps you see how food affects your health with data from biosensors like continuous glucose monitors (CGMs)
Blackrock Neurotech — Blackrock Neurotech innovative brain technologies provide new hope for people with paralysis & other neurological disorders.

Reinhard Ambros

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Series C
United States, Switzerland

Portfolio highlights

FORMA Therapeutics — FORMA Therapeutics is a biopharmaceutical company integrating transformative biology and chemistry to unlock targets and pathways that have been validated through genomic medicine as root causes or major drivers of human cancers.FORMAâ€™s approach to accessing such high value drug targets, many of which pose significant challenges toconventional discovery approaches, is rooted in the concerted integration of its innovative drug discovery technologies and oncology expertise, enabling screening, discovery and rational development of a generation of small molecule drug candidates with cellular mechanisms of action. FORMA is building a pipeline of therapeutics directed at Achilles heels in human cancers, such as key targets associated with cancer stem cells, tumor cell metabolism, programmed cell death or epigenetic disease mechanisms.FORMA builds on the vision of its academic founders: Stuart Schreiber, Todd Golub and Michael Foley, each of the Broad Institute of Harvard and MIT. FORMA leverages its innovative drug discovery platform to address challenging targets and develop a robust internal pipeline of breakthrough oncology drugs.
Aileron Therapeutics — Aileron Therapeutics - ALRN-6924 - myelopreservation
ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.

Lukas Speiser is the founder and CEO of Amorana.ch

Investment focus

Wellness, Nutrition, Health Care
Seed
Germany, Switzerland

Portfolio highlights

feey — feey is a houseplant shop. They offer plants that include entry-level plants, baby plants, animal-friendly plants, large plants, home office plants, hanging plants, aglaonema, alocasia, calathea, hoya, monstera, and philodendron.
Sleepiz — Sleepiz is a Zürich based startup with the aim to enable the medical community to take healthcare into the home environment. Sleepiz provides an easy and comfortable to use solution with a device that is simply placed on the bedside table. The device operates in a non-contact fashion and measures movements originating from heart contractions andbreathing patterns as well as body motions with medical grade accuracy.By making use of wireless millimeter wave technology, sensor fusion and artificial intelligence Sleepiz will in the future not only able to diagnose sleep disorders, but also to perform long-term monitoring. Thereby, the progression of chronic diseases can be monitored to allow faster intervention and better treatment.
Dunatura — Dunatura engages in the manufacture and supply of vitamins and micronutrients.

Tobias Reichmuth - Founding Partner at Maximon - The Longevity Company Builder @ Maximon

Investment focus

E-Commerce, Travel, Internet
Seed, Angel, Pre-Seed
Switzerland

Portfolio highlights

Firstcar — Firstcar provides car driving learning assistant services. They offer services that include hand-picked driving schools, student cars with double pedals for rent before and for the driving test, entry-level vehicles that are inexpensive to buy and maintain, support and advice on vehicle purchase, and selected insurances with special rates.
MyFeld.ch — remi 101 com login adalah apk open slot admin 75 wbet apk download 75 wbet apk download beli chip scatter OLX500.
Testmate Health — 2 in 1 urine test with immediate results for Chlamydia trachomatis and Neisseria gonorrhoeae. Results within minutes & 100% anonymous.

As an early pioneer in long DNA synthesis, Emily is poised to accelerate the biofactory market. She and co-founder Bill Peck share the world record for synthesizing the longest, highest quality oligo library. Emily architected the successful SureSelect product line which lowered the cost of sequencing and elucidated dozens of mendelian diseases,and she developed Agilent’s Oligo Library Synthesis technology. Emily has co-authored over 34 peer-reviewed papers—many on synthetic DNA—and has extensive marketing, management, and business development experience. Prior to Twist Bioscience, Emily was Director of Applications and Chemistry R&D—Genomics at Agilent Technologies.

Investment focus

Biotechnology, Health Care, Product Research
Seed
Switzerland, United States

Portfolio highlights

Biostate AI — Biostate AI develops generative AI that benefit all human health.
Cradle — Engineer Better Proteins Faster. AI for modern protein engineering teams.
Kiwi Biosciences — Kiwi biosciences is a biotech company that develops enzymes to make food for patients who suffer from Irritable Bowel Syndrome (IBS). The company was founded in 2020 and is based in Somerville, Massachusetts, United States.

Patrick is a businessman active in real estate, wealth management, show business, hospitality, education and private equity, benefiting from a strong network. At Biowatch since November 2015.

Investment focus

Security, Wireless, Wearables
Seed
Switzerland

Portfolio highlights

Biowatch — Biowatch is a user-friendly wrist veins biometric reader that functions as a security solution for mobile payment protection and smart device interaction. Users can access the app for enrolling their vein pattern and selecting applications and devices that needs to be connected to their Biowatch, wear their BioWatch and activate it by matchingtheir vein pattern with their enrolled reference, get PKI encrypted user code transmitted from their Biowatch, and start opening doors without the use of keys and passwords.Biowatch was launched by Joe Rice and Matthias Vanoni and is headquartered in Lausanne, Switzerland.

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Investment focus

Biotechnology, Health Care, Life Science
Series A, Seed
United States, France, Switzerland

Portfolio highlights

Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
Cradle — Engineer Better Proteins Faster. AI for modern protein engineering teams.
Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.

Feike has been the CEO and Chairman of the Managing Board of Directors of Royal DSM N.V. (a global Life Sciences and Materials Sciences company) since May 2007. In 1995, Feike became director of Gist-Brocades Food Specialties Division and joined Gist-Brocade’s executive committee. Following the acquisition by Royal DSM N.V. in 1998, he became adirector of the business group DSM Food Specialties. In 2000 he joined Royal DSM’s managing board of directors, becoming Chairman and CEO in May 2007.He is currently a member of the supervisory board of De Nederlandsche Bank (DNB, the Dutch Central Bank), and a board member of CEFIC (European Chemical Industry Council) and member of the Global CEO Council (GCC) of the Chinese People’s Association for Friendship with Foreign Countries (CPAFFC).His previous roles have included member of the Supervisory Board of DSM Netherlands, the Utrecht University, the Dutch Genomics Initiative (NGI) and the Anthonie van Leeuwenhoek Hospital/Netherlands Cancer Institute (NKI/AVL), chairman of Chemical Governors and a Global Agenda Council of the World Economic Forum, Dutch Food Chain Sustainability Foundation (DUVO) and of EuropaBio (European Biotech Association), a member of the Dutch Innovation Platform 2.0, board member of BIO (US Biotechnology Association), the Swiss Society of Chemical Industries (SCGI) and the Dutch Nutrition/Food Top-Institute (WCFS) and a member of the advisory board of ECP-EPN (e-commerce) and the Rotterdam Business School of the Erasmus University.

Investment focus

Biotechnology, Product Research
Seed
Switzerland

Portfolio highlights

Cradle — Engineer Better Proteins Faster. AI for modern protein engineering teams.
Basecamp Research — Novel proteins from nature. We sample the most extreme and exciting places on the planet to build the world's largest knowledge graph of natural biodiversity.

Lucian has a truly global outlook with an extensive set of contacts in North America, Europe, and Asia. Lucian is a venture capitalist and entrepreneur with several successful start-ups to his credit. He has 20 years of semiconductor industry experience. Lucian was born in Germany, educated in the French school system, and went on to earn a B.Sc.in International Economics from the School of Foreign Service at Georgetown University (with a minor in Russian) and an MBA from INSEAD.

Investment focus

Skiing, Sports, Fitness
Seed
Switzerland

Portfolio highlights

Adiposs — Adiposs is a Swiss biotech start-up company developing medical imaging products and technologies for early detection of cachexia.
Snowcookie — Ski tracking sensors by bode miller for racers and coaches

Tom Glocer joined BlueVoyant as Executive Chairman and Founder in 2017.

Investment focus

Software, FinTech, Analytics
Seed, Series A, Series C
United States, United Kingdom, Israel

Portfolio highlights

Superlegal — Superlegal, the world's #1 contract automation platform, is the fastest, easiest and most cost effective way to negotiate and close deals.
Cradle — Engineer Better Proteins Faster. AI for modern protein engineering teams.
Black Ore Technologies — Black Ore's Tax Autopilot is the first AI tax platform for CPAs, offering complete 1040 tax preparation automation to tax professionals, so they can focus on growing their firm.

Zürcher Kantonalbankand

Investment focus

Medical Device, Energy, Medical
Seed, Series A, Series B
Switzerland

Portfolio highlights

matriq — matriq offers innovative solutions for the part-individual marking of plastic components of all kinds. With the DynamicMold technology, marking takes place directly in the manufacturing machine, whether in injection molding, blow molding or thermoforming. Besides the application for traceability, the DynamicMold technology also offers thepossibility to integrate product protection.
Aspivix — ASPIVIX is developing a new generation of medical devices that make gynecological procedures gentler and safer for women and gynecologists. The first device, CAREVIX, is designed to prevent cervix bleeding using a suction technology to replace traumatic tenaculum (forceps).
Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.

John Zimmer is the co-founder and President of Lyft, the on-demand ridesharing platform, that was founded in 2007 with Zimride as its first of two products built to create a more social, sustainable and affordable transportation system. John’s interest in peer-to-peer transportation began at Cornell’s School of Hotel Administration. Uponlearning that only 20% of seats in cars on highways are occupied, he began working on ways to use existing information infrastructures to solve the problem of unused empty seats. After graduating first in his class, John spent two years at Lehman Brothers before (luckily) leaving to rideshare his way from New York to San Francisco to join co-founder Logan Green in launching Zimride. John was recognized in 2009 as one of Businessweek's Top 25 Entrepreneurs Under 25, and has spoken at top tier events such as SXSW, The Association for Commuter Transportation (ACT) International Conference and Stanford Business School. With Lyft, John hopes to fix the current state of transportation across the country, and eventually around the world, to make cities safer, more affordable and better connected. Since unveiling the product in June 2012, Lyft has quickly become one of the fastest-growing tech companies with more than $80 million raised from leading investors Andreessen Horowitz and Founders Fund and has been featured in The Economist, the New York Times and on NBC’s TODAY Show. Lyft is currently available in San Francisco, Los Angeles, Seattle, San Diego, Chicago, Boston and Washington, D.C., with more than a million rides shared on the platform to date.

Investment focus

Mining, FinTech, Mineral
Series B, Seed
United States, Switzerland

Portfolio highlights

Deel — With Deel, your business can easily hire anywhere. No more worrying about local laws, complex tax systems, or managing international payroll. Deel takes care of everything in 150+ countries.
Cradle — Engineer Better Proteins Faster. AI for modern protein engineering teams.
KoBold Metals — KoBold Metals is investing in battery materials projects across the globe by combining basic ore-deposit science, big data, and scientific computing with patient private capital.The company's software uses datasets with conventional geochemical, geophysical and geological data in statistical association models to identify prospects to ensure acobalt supply for the electric vehicle revolution, enabling mineral exploration companies to find new sources of cobalt through machine learning and data analysis.

Walter Fischl

Investment focus

Medical, Health Care, Biotechnology
Funding Round
Switzerland

Portfolio highlights

ProteoMediX — ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer and the personalized treatment thereof.The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinicalstandard.This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.

Beat Schillig - Founder @ Venture Kick

Investment focus

Information Technology, SaaS, Music
Seed, Series A
Switzerland

Portfolio highlights

TYXIT — TYXIT is linking musicians wirelessly without configuration, allowing a personal audio monitoring.
PXL Vision — PXL Vision enables state-of-the-art digital identity verification. PXL Vision's highly flexible technology solution helps global customers build trust digitally...
1Drop Diagnostics — 1Drop Diagnostics is a cutting edge medical diagnostics and life science company. They combine the best techniques from microfluidics, biochemistry, photonics and information technology to build high performance point-of-care diagnostics devices.Their vision is to provide high quality medical information for everyone. They aim to increase accessto quality healthcare by providing laboratory quality, easy to use, medical diagnostics in any setting. The 1Drop Diagnostics system is being developed for a broad menu of clinical applications including multiplexed assays of proteins, nucleic acids and peptides. Their first clinical applications are in the screening, diagnostics and monitoring of cardiovascular disease and infectious disease.Their mission is to improve patient lives by enabling precision medicine through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. They facilitate the early detection, prevention and management of disease. They empower people to live better lives.

Alexsis is the Founder and Managing Partner of Merian Ventures, an early-stage venture firm focused on investing in women founded, co-founded and majority-owned companies in the US and UK. Alexsis has extensive investment, venture and operations experience based on businesses she has founded or funded. As managing partner of Merian Ventures since2015, Alexsis serves as a Board Member and Advisor to Merian Venture portfolio companies Provenance, Pivigo, Populus, Honeycomb, ImpactVision, CareerLark, Cirrus Identity and Compaas, among others. Merian Ventures was named after Maria Sibylla Merian, a botanist, entrepreneur and intrepid traveler born in 1647. In addition to Merian Ventures, Alexsis is a US-UK Fulbright Commissioner; Board member of the Oxford Internet Institute; Board member of The Oxford Foundry; Founder and funder of the WEInnovate STEM accelerator for Women at Imperial College, London; and Board Member and Advisor to companies she's funded. Alexsis is also Chairman and Founder of The Althea Foundation, established in 2003 as a family office. Today, The Althea Foundation is a California nonprofit public benefit corporation and it is recognized by the Internal Revenue Service as a public charity described in Internal Revenue Code Sections 501(c)(3) and 509(a)(1).

Investment focus

Software, SaaS, Health Care
Seed, Series A, Series B
United States, Switzerland, United Kingdom

Portfolio highlights

Aiden — Reduce risk, enhance compliance, and simplify IT with modern, intelligent software packaging and deployment using Artificial Intelligence.
Compaas — Compaas: The Compensation Platform | Total Visibility. Zero Spreadsheets. Painless raise cycles, compensation metrics, people analytics, rewards letters
Provenance — Provenance is a software solution for sustainability communications and supply chain transparency.

Investors by industry

Artificial intelligence